EUCTR2005-004569-40-IT进行中（未招募）不适用
Phase I and II perspective study with Citrate in Liposoma not Pegilate Doxorubicine TLC D-99 in association to Ifosfamide in patients with metastatic soft tissue sarcoma.
ISTITUTO CLINICO HUMANITAS0 个研究点目标入组 52 人开始时间: 2006年12月22日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 52
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
尚未招募
1 期
Clinical studies to check the effectiveness of neutracitical Nanoparticles for its Bilirubin reduction propertiesCTRI/2024/07/071406Indian Council of Medical Research
已完成
不适用
Comparison of the efficacy of potassium citrate and poly citra-k in children and infant with urolithiasisrolithiasis.Calculus of kidney with calculus of ureterN23-N20IRCT2016121931466N1Vice chancellor for research of Ardebil University of Medical Science70
招募中
4 期
se of citrate content dialysate in patients on hemodialysisN18.0Chronic kidney diseaseRBR-2z9xybDivisão de Nefrologia da Faculdade de Medicina da Universidade Federal Fluminense
已完成
不适用
A comparative study of the therapeutic effect of cetirizine and fexofenadine on the control of skin lesions caused by drugs in the intensive care unit(ICU).IRCT20080901001165N47Islamic Azad University60
进行中（未招募）
1 期
Phase II study on the safety and efficacy of cysteamine in association with standard tuberculosis therapy for the treatment of patients with pulmonary tuberculosis: a new therapy for tuberculosis directed at the hostPulmonary Mycobacterium tuberculosis infectionMedDRA version: 20.0Level: PTClassification code 10037440Term: Pulmonary tuberculosisSystem Organ Class: 10021881 - Infections and infestationsEUCTR2019-002514-40-ITISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI30